Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Capital V LLC10% Owner | Option exercise · 10b5-1 plan | M | — 37.5K sh | Apr 22, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | $81K 7,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Sehmi HarminderChief Financial Officer | Option exercise · 10b5-1 plan | M | — 505.1K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | $47K 2,845 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 54.2K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Hyep IvanChief Financial Officer | Option exercise · 10b5-1 plan | M | $35K 9,200 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | $28K 5,553 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Capital V LLC10% Owner | Option exercise · 10b5-1 plan | M | — 37.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | — 1,500 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 0 | Arora TarunChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $41K 953 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | — 7,714 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Capital V LLC10% Owner | Disposition to issuer · 10b5-1 plan | D | — 37.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venker EricPresident & Immunovant CEO | Option exercise · 10b5-1 plan | M | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | — 7,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | $25K 1,500 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 47 | Maria Elvira SalazarRSelf | Purchase | BUY | $15K – $50K | Apr 21, 2026 traded Mar 19, 2026 |
| 47 | Maria Elvira SalazarRSelf | Purchase | BUY | $15K – $50K | Apr 21, 2026 traded Mar 19, 2026 |
| 43 | Casper MarkEVP & Chief Legal Officer | Open-market sale | SELL | $1.35M 10.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 42 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $23.67M 205.8K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 42 | Golten Alex SCHIEF RISK OFFICER | Open-market sale | SELL | $649K 706 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 42 | Golten Alex SCHIEF RISK OFFICER | Open-market sale | SELL | $376K 409 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 41 | Bawa AparnaChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $1.05M 12.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 40 | Soule Randy10% Owner | Open-market sale | SELL | $656K 1.26M sh | Apr 21, 2026 traded Mar 12, 2026 |
| 38 | Maria Elvira SalazarRSelf | Purchase | BUY | $1,001 – $15K | Apr 21, 2026 traded Mar 19, 2026 |
| 37 | Maria Elvira SalazarRSelf | Purchase | BUY | $15K – $50K | Apr 21, 2026 traded Mar 19, 2026 |
| 37 | Maria Elvira SalazarRSelf | Purchase | BUY | $15K – $50K | Apr 21, 2026 traded Mar 19, 2026 |
| 37 | Maria Elvira SalazarRSelf | Purchase | BUY | $15K – $50K | Apr 21, 2026 traded Mar 19, 2026 |
| 37 | Maria Elvira SalazarRSelf | Purchase | BUY | $15K – $50K | Apr 21, 2026 traded Mar 19, 2026 |
| 37 | Maria Elvira SalazarRSelf | Purchase | BUY | $15K – $50K | Apr 21, 2026 traded Mar 19, 2026 |
| 37 | Duda KennethDirector, President and CTO | Open-market sale · 10b5-1 plan | SELL | $1.60M 9,892 sh | Apr 21, 2026 traded Apr 17, 2026 |